| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/04/2004 | WO2003012034A9 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002078640A3 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044192 Genetic engineered polypeptide; diagnosis of Lyme disease |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044187 Chimeric immunoglobulin for prevention and treatment blood, tumor, cardiovascular and urogenital disorders |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040044179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/04/2004 | US20040043953 Genetic engineering; culture product |
| 03/04/2004 | US20040043949 Therapeutic system targeting pathogen proteases and uses thereof |
| 03/04/2004 | US20040043935 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/04/2004 | US20040043930 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043451 Production process of surfactin |
| 03/04/2004 | US20040043444 Fermentation process using specific oxygen uptake rates as a process control |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043406 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043397 Identification and isolation of novel DNA and the recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043384 In vitro protein translation microarray device |
| 03/04/2004 | US20040043381 Multiple sclerosis associated retrovirus (MSRV) -1 ; long terminal repeat sequences (LTR) |
| 03/04/2004 | US20040043088 Milling plant seeds; separation by flotation |
| 03/04/2004 | US20040043028 Methods and compositions for enhanced protein expression and/or growth of cultured cells using co-transcription of a Bcl2 encoding nucleic acid |
| 03/04/2004 | US20040041678 Metalized polyester film with heat-seal layer on opposite side for flyback transformer application |
| 03/04/2004 | CA2496572A1 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
| 03/03/2004 | EP1394261A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394253A1 Anti-human ovarian cancer -anti-cd3 bispecific antibody |
| 03/03/2004 | EP1394179A1 Process for producing erythropoietin free from animal proteins |
| 03/03/2004 | EP1393746A1 Human polyclonal antibody compositions |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392842A2 Recombinant vaccinia viral vectors |
| 03/03/2004 | EP1392841A2 Enzymatic coupling of l-phenylalanine methyl ester and n-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process |
| 03/03/2004 | EP1392840A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 03/03/2004 | EP1392835A2 Expression vector using for animal cell |
| 03/03/2004 | EP1392831A2 Moraxella(branhamella) catarrhalis antigens |
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392821A1 Dna molecules encoding macaca mulatta androgen receptor |
| 03/03/2004 | EP1392815A2 Enzymes having alpha amylase activity and methods of use thereof |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1392717A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/03/2004 | EP1392715A2 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 03/03/2004 | EP1392360A2 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/03/2004 | EP1392359A2 Specific binding proteins and uses thereof |
| 03/03/2004 | EP1392342A1 Global analysis of protein activities using proteome chips |
| 03/03/2004 | EP1149167B1 Viral vaccine |
| 03/03/2004 | EP1104993A4 C3a serum-free clonal cell line and methods of use |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/03/2004 | EP1023467B1 Method for measuring viral infectivity |
| 03/03/2004 | EP0964875B1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0647268B1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 03/03/2004 | CN1479789A Genes of corynebacteria |
| 03/03/2004 | CN1479748A Anti-abnormal prion monoclonal antibody, process for producing the same and immunoassay method with the use thereof |
| 03/03/2004 | CN1479739A Heterocyclic ether substituted imidazoquinolie compounds |
| 03/03/2004 | CN1479738A Thioether subsituted imidazoquinoline compound |
| 03/03/2004 | CN1478903A Method of preparing human carried lipoprotein gene recombination protein |
| 03/03/2004 | CN1478896A Method of colibacillus expression alpha foetoprotein |
| 03/03/2004 | CN1478543A Therapeutic use of bactericidal/permeability improving protein product |
| 03/03/2004 | CN1140295C Platelet-special chimeric immunoglobulin and method of use thereof |
| 03/02/2004 | US6699979 Oligonucleotides having chiral phosphorus linkages |
| 03/02/2004 | US6699974 Reshaped human anti-HM 1.24 antibody |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699692 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
| 03/02/2004 | US6699691 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 03/02/2004 | US6699689 Mass production method of antimicrobial peptide and DNA construct and expression system thereof |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004016792A1 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016789A1 Sugar chain library constructed via cargo receptor gene modification |
| 02/26/2004 | WO2004016778A1 Improved methods of in vitro protein synthesis |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2004016740A2 Humanized rabbit antibodies |
| 02/26/2004 | WO2004000881A9 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 02/26/2004 | WO2003083435A3 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
| 02/26/2004 | WO2003083066A3 Methods for increasing polypeptide production |
| 02/26/2004 | WO2003073982A3 Anti-interleukin-1 beta analogs |
| 02/26/2004 | WO2003068926A3 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003059953B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |